Wolverine Asset Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-47,895
| Closed | -$162K | – | 1420 |
|
|
2018
Q3 | $162K | Buy |
47,895
+19,484
| +69% | +$65.9K | ﹤0.01% | 812 |
|
|
2018
Q2 | $106K | Hold |
28,411
| – | – | ﹤0.01% | 797 |
|
|
2018
Q1 | $116K | Sell |
28,411
-655
| -2% | -$2.67K | ﹤0.01% | 811 |
|
|
2017
Q4 | $135K | Buy |
29,066
+12,472
| +75% | +$57.9K | ﹤0.01% | 714 |
|
|
2017
Q3 | $117K | Sell |
16,594
-2,406
| -13% | -$17K | ﹤0.01% | 655 |
|
|
2017
Q2 | $137K | Buy |
+19,000
| New | +$137K | ﹤0.01% | 619 |
|
|
2016
Q1 | – | Sell |
-5,751
| Closed | -$29K | – | 1273 |
|
|
2015
Q4 | $29K | Sell |
5,751
-83,675
| -94% | -$422K | ﹤0.01% | 851 |
|
|
2015
Q3 | $314K | Buy |
89,426
+39,086
| +78% | +$137K | 0.01% | 615 |
|
|
2015
Q2 | $502K | Buy |
50,340
+48,300
| +2,368% | +$482K | 0.01% | 531 |
|
|
2015
Q1 | $25K | Sell |
2,040
-1,000
| -33% | -$12.3K | ﹤0.01% | 904 |
|
|
2014
Q4 | $43K | Sell |
3,040
-3,700
| -55% | -$52.3K | ﹤0.01% | 924 |
|
|
2014
Q3 | $92K | Sell |
6,740
-300
| -4% | -$4.1K | ﹤0.01% | 915 |
|
|
2014
Q2 | $108K | Hold |
7,040
| – | – | ﹤0.01% | 775 |
|
|
2014
Q1 | $119K | Sell |
7,040
-600
| -8% | -$10.1K | ﹤0.01% | 766 |
|
|
2013
Q4 | $98K | Sell |
7,640
-26,000
| -77% | -$334K | ﹤0.01% | 994 |
|
|
2013
Q3 | $339K | Buy |
33,640
+20,000
| +147% | +$202K | 0.01% | 692 |
|
|
2013
Q2 | $101K | Buy |
+13,640
| New | +$101K | ﹤0.01% | 884 |
|